Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Twin epidemics: The surging rise of methamphetamine use in chronic opioid users
Matthew S. Ellis, Zachary A. Kasper, Theodore J. Cicero
Drug and Alcohol Dependence (2018) Vol. 193, pp. 14-20
Closed Access | Times Cited: 308

Showing 1-25 of 308 citing articles:

Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Alexander C. Tsai, Mathew V. Kiang, Michael L. Barnett, et al.
PLoS Medicine (2019) Vol. 16, Iss. 11, pp. e1002969-e1002969
Open Access | Times Cited: 317
Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine — 25 States, July–December 2017 to January–June 2018
R. Matt Gladden, Julie O’Donnell, Christine L. Mattson, et al.
MMWR Morbidity and Mortality Weekly Report (2019) Vol. 68, Iss. 34, pp. 737-744
Open Access | Times Cited: 260
Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis
Theodore J. Cicero, Matthew S. Ellis, Zachary A. Kasper
American Journal of Public Health (2019) Vol. 110, Iss. 2, pp. 244-250
Open Access | Times Cited: 223
One Is Not Enough: Understanding and Modeling Polysubstance Use
Elizabeth A. Crummy, Timothy J. O’Neal, Britahny M. Baskin, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 222
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults
Beth Han, Wilson M. Compton, Christopher M. Jones, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 12, pp. 1329-1329
Open Access | Times Cited: 218
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder
Martin P. Paulus, Jennifer L. Stewart
JAMA Psychiatry (2020) Vol. 77, Iss. 9, pp. 959-959
Open Access | Times Cited: 201
Bupropion and Naltrexone in Methamphetamine Use Disorder
Madhukar H. Trivedi, Robrina Walker, Walter Ling, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 2, pp. 140-153
Open Access | Times Cited: 192
Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction
Christopher M. Jones, Debra Houry, Beth Han, et al.
Annals of the New York Academy of Sciences (2021) Vol. 1508, Iss. 1, pp. 3-22
Open Access | Times Cited: 111
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17
Christopher M. Jones, Natasha Underwood, Wilson M. Compton
Addiction (2019) Vol. 115, Iss. 2, pp. 347-353
Open Access | Times Cited: 126
The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms
Christopher M. Jones, Faraah N Bekheet, Ju Nyeong Park, et al.
Epidemiologic Reviews (2020) Vol. 42, Iss. 1, pp. 154-166
Open Access | Times Cited: 126
Pharmacotherapy for methamphetamine/amphetamine use disorder—a systematic review and meta‐analysis
Brian Chan, Michele Freeman, Karli Kondo, et al.
Addiction (2019) Vol. 114, Iss. 12, pp. 2122-2136
Closed Access | Times Cited: 115
A nationally representative analysis of “twin epidemics”: Rising rates of methamphetamine use among persons who use opioids
Justin C. Strickland, Jennifer R. Havens, William W. Stoops
Drug and Alcohol Dependence (2019) Vol. 204, pp. 107592-107592
Open Access | Times Cited: 111
Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011–2016
Ju Nyeong Park, Emaan Rashidi, Kathryn Foti, et al.
Drug and Alcohol Dependence (2020) Vol. 218, pp. 108416-108416
Open Access | Times Cited: 98
Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008–2017
Christopher M. Jones, Emily O’Malley Olsen, Julie O’Donnell, et al.
American Journal of Public Health (2020) Vol. 110, Iss. 4, pp. 509-516
Open Access | Times Cited: 95
Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007–2019
Tarlise Townsend, David Kline, Ariadne Rivera‐Aguirre, et al.
American Journal of Epidemiology (2021) Vol. 191, Iss. 4, pp. 599-612
Open Access | Times Cited: 80
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors
Andrea López, Zena Dhatt, Mary Howe, et al.
International Journal of Drug Policy (2021) Vol. 91, pp. 103098-103098
Open Access | Times Cited: 63
The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings
Rebecca Bolinski, Suzan M. Walters, Elizabeth Salisbury‐Afshar, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 4, pp. 2230-2230
Open Access | Times Cited: 63
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis
Richard A. Jenkins, Bridget M. Whitney, Robin M. Nance, et al.
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 46
Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study
Heather Palis, Chloé G. Xavier, Sabina Dobrer, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence
Michèle Boileau-Falardeau, Gisèle Contreras, Geneviève Gariépy, et al.
Health Promotion and Chronic Disease Prevention in Canada (2022) Vol. 42, Iss. 2, pp. 47-59
Open Access | Times Cited: 41
Attitudes and experiences with fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs
Raminta Daniulaityte, Lance Ruhter, Matthew Juhascik, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Polysubstance Use Among Pregnant Women With Opioid Use Disorder in the United States, 2007–2016
Marian Jarlenski, Nicole Paul, Elizabeth E. Krans
Obstetrics and Gynecology (2020) Vol. 136, Iss. 3, pp. 556-564
Open Access | Times Cited: 63
Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern U.S. City
Raminta Daniulaityte, Sydney M. Silverstein, Timothy N. Crawford, et al.
Substance Use & Misuse (2020) Vol. 55, Iss. 11, pp. 1781-1789
Open Access | Times Cited: 57
Interoceptive attention in opioid and stimulant use disorder
Jennifer L. Stewart, Sahib S. Khalsa, Rayus Kuplicki, et al.
Addiction Biology (2019) Vol. 25, Iss. 6
Open Access | Times Cited: 54
Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service
Honora Englander, Caroline King, Christina Nicolaidis, et al.
Journal of Addiction Medicine (2019) Vol. 14, Iss. 5, pp. 415-422
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top